Literature DB >> 24617566

Critical review of the prognostic significance of pathological variables in patients undergoing resection for colorectal liver metastases.

Dhanwant Gomez1, Abed M Zaitoun, Antonella De Rosa, Sina Hossaini, Ian J Beckingham, Adam Brooks, Iain C Cameron.   

Abstract

OBJECTIVE: The aim of this study was to identify prognostic factors, particularly pathological variables, that influence disease-free and overall survival following resection for colorectal liver metastases (CRLM).
METHODS: Patients undergoing CRLM resection from January 2005 to December 2011 were included. Data analysed included information on demographics, laboratory results, operative findings, histopathological features and survival.
RESULTS: A total of 259 patients were included. Of these, 138 (53.3%) patients developed recurrent disease, of which 95 died. The median length of follow-up in the remaining patients was 28 months (range: 12-96 months). There were significant associations between recurrence and higher tumour number (P = 0.002), presence of perineural invasion (P = 0.009) and positive margin (R1) resection (P = 0.002). Multivariate analysis showed all three prognostic factors to be independent predictors of disease-free survival. Significantly poorer overall survival after hepatic resection for CRLM was observed in patients undergoing hemi-hepatectomy or more radical resection (P = 0.021), patients with a higher number of tumours (P = 0.024) and patients with perineural invasion (P < 0.001). Multivariate analysis showed perineural invasion to be the only independent predictor of overall survival.
CONCLUSIONS: The presence of perineural invasion, multiple tumours and an R1 margin were associated with recurrent disease. Perineural invasion was also an independent prognostic factor with respect to overall survival.
© 2014 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2014        PMID: 24617566      PMCID: PMC4159457          DOI: 10.1111/hpb.12216

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  38 in total

1.  Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin.

Authors:  K Shirabe; K Takenaka; T Gion; Y Fujiwara; M Shimada; K Yanaga; T Maeda; K Kajiyama; K Sugimachi
Journal:  Br J Surg       Date:  1997-08       Impact factor: 6.939

2.  Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history.

Authors:  J Scheele; R Stangl; A Altendorf-Hofmann
Journal:  Br J Surg       Date:  1990-11       Impact factor: 6.939

3.  Macroscopic intrabiliary growth of liver metastases from colorectal cancer.

Authors:  K Okano; J Yamamoto; Y Moriya; T Akasu; T Kosuge; M Sakamoto; S Hirohashi
Journal:  Surgery       Date:  1999-11       Impact factor: 3.982

4.  Long-term survival following resection of colorectal hepatic metastases. Association Française de Chirurgie.

Authors:  D Jaeck; P Bachellier; M Guiguet; K Boudjema; J C Vaillant; P Balladur; B Nordlinger
Journal:  Br J Surg       Date:  1997-07       Impact factor: 6.939

5.  Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).

Authors:  Felix G Fernandez; Jeffrey A Drebin; David C Linehan; Farrokh Dehdashti; Barry A Siegel; Steven M Strasberg
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

6.  Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma.

Authors:  Yoshifumi Kawarada; Kentaro Yamagiwa; Bidhan C Das
Journal:  Am J Surg       Date:  2002-06       Impact factor: 2.565

Review 7.  Histopathological evaluation of resected colorectal cancer liver metastases: what should be done?

Authors:  Nikki Knijn; Jannemarie A M de Ridder; Cornelis J A Punt; Johannes H W de Wilt; Iris D Nagtegaal
Journal:  Histopathology       Date:  2013-06-13       Impact factor: 5.087

8.  Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer.

Authors:  J Yamamoto; K Sugihara; T Kosuge; T Takayama; K Shimada; S Yamasaki; M Sakamoto; S Hirohashi
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

9.  Prognostic significance of intrahepatic lymphatic invasion in patients with hepatic resection due to metastases from colorectal carcinoma.

Authors:  Atsushi Sasaki; Masanori Aramaki; Katsunori Kawano; Kazuhiro Yasuda; Masafumi Inomata; Seigo Kitano
Journal:  Cancer       Date:  2002-07-01       Impact factor: 6.860

10.  Lymphocytic infiltration surrounding liver metastases from colorectal cancer.

Authors:  Keiichi Okano; Takashi Maeba; Akito Moroguchi; Ken Ishimura; Yukihiko Karasawa; Kunihiko Izuishi; Fuminori Goda; Hisashi Usuki; Hisao Wakabayashi; Hajime Maeta
Journal:  J Surg Oncol       Date:  2003-01       Impact factor: 3.454

View more
  9 in total

1.  Rectal Cancer in Patients Under 50 Years of Age.

Authors:  A M Dinaux; L G J Leijssen; L G Bordeianou; H Kunitake; D L Berger
Journal:  J Gastrointest Surg       Date:  2017-08-25       Impact factor: 3.452

2.  The Prognostic Value of Varying Definitions of Positive Resection Margin in Patients with Colorectal Cancer Liver Metastases.

Authors:  Jane Wang; Georgios Antonios Margonis; Neda Amini; Nikolaos Andreatos; Chunhui Yuan; Christos Damaskos; Efstathios Antoniou; Nikolaos Garmpis; Stefan Buettner; Carlotta Barbon; Amar Deshwar; Jin He; Richard Burkhart; Timothy M Pawlik; Christopher L Wolfgang; Matthew J Weiss
Journal:  J Gastrointest Surg       Date:  2018-04-09       Impact factor: 3.452

3.  Histopathological prognostic factors for colorectal liver metastases: A systematic review and meta-analysis of observational studies.

Authors:  Cássio Virgílio Cavalcante de Oliveira; Gilton Marques Fonseca; Jaime Arthur Pirola Kruger; Evandro Sobroza de Mello; Fabricio Ferreira Coelho; Paulo Herman
Journal:  Histol Histopathol       Date:  2020-11-09       Impact factor: 2.303

4.  Resection margin influences the outcome of patients with bilobar colorectal liver metastases.

Authors:  Sara Di Carlo; Derek Yeung; Jamie Mills; Abed Zaitoun; Iain Cameron; Dhanny Gomez
Journal:  World J Hepatol       Date:  2016-12-08

5.  Colon liver metastasis complicated with tumor thrombus in the bile duct: A case report.

Authors:  Yoshifumi Watanabe; Hiroshi Tamagawa; Tsunekazu Mizushima; Eiji Taniguchi; Hiroyuki Kikkawa; Masaru Sasaki; Hiroyuki Nakaba
Journal:  Int J Surg Case Rep       Date:  2018-07-09

6.  Comparison of the eighth version of the American Joint Committee on Cancer manual to the seventh version for colorectal cancer: A retrospective review of our data.

Authors:  Guo-Jun Tong; Gui-Yang Zhang; Jian Liu; Zhao-Zheng Zheng; Yan Chen; Ping-Ping Niu; Xu-Ting Xu
Journal:  World J Clin Oncol       Date:  2018-11-10

7.  Retrospective cohort study of statin therapy effect on resected colorectal liver metastases.

Authors:  Edward Alabraba; Hussain Ibrahim; Adina Olaru; Iain Cameron; Dhanny Gomez; Nottingham Hpb Surgery Group
Journal:  World J Gastrointest Surg       Date:  2020-02-27

Review 8.  Nerve Density and Neuronal Biomarkers in Cancer.

Authors:  Shahrukh R Ali; Madeleine Jordan; Priyadharsini Nagarajan; Moran Amit
Journal:  Cancers (Basel)       Date:  2022-10-01       Impact factor: 6.575

9.  Parenchyma-sparing hepatectomy (PSH) versus non-PSH for bilobar liver metastases of colorectal cancer.

Authors:  Lidewij Spelt; Daniel Ansari; Max Swanling; Peter Holka; Roland Andersson
Journal:  Ann Gastroenterol       Date:  2017-10-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.